Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oestrogen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01217411
What this trial is testing

RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer

Who this might be right for
Adult Solid NeoplasmExtensive Stage Lung Small Cell CarcinomaHER2/Neu Negative+10 more
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Looking for participantsNCT03675893
What this trial is testing

RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer

Who this might be right for
Endometrial Cancer
Dana-Farber Cancer Institute 110
Not applicableEnded earlyNCT03619044
What this trial is testing

The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane.

Who this might be right for
HER2-positive Breast Cancer
Institut Claudius Regaud 4
Not applicableStudy completedNCT06925633
What this trial is testing

Estrogen Levels and Postoperative Recovery in IVF Patients

Who this might be right for
In Vitro FertilizationPostoperative RecoveryEstrogens+1 more
Konya City Hospital 98
Not applicableUnknownNCT05135104
What this trial is testing

Study Of Real-World Evidence In Patients Treated With Palbociclib During a 2.5 Years Follow-Up Period

Who this might be right for
Metastatic Breast Cancer
Asociatia Oncohelp - Centrul de Oncologie Oncohelp 650
Testing effectiveness (Phase 2)Ended earlyNCT02273752
What this trial is testing

Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerGastrinomaGlucagonoma+16 more
Emory University 2
Testing effectiveness (Phase 2)UnknownNCT04669587
What this trial is testing

ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study)

Who this might be right for
Estrogen Receptor-PositiveHER2-NegativeLocally Advanced Breast Cancer+1 more
EnhancedBio USA Inc. 106
Testing effectiveness (Phase 2)Study completedNCT00580333
What this trial is testing

Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer

Who this might be right for
Breast Cancer
Massachusetts General Hospital 51
Testing effectiveness (Phase 2)WithdrawnNCT05073237
What this trial is testing

Effects of Novel Estrogens on Glucose and Lipids in Postmenopausal Prediabetic Women Veterans

Who this might be right for
MenopausePrediabetesObesity
VA Office of Research and Development
Testing effectiveness (Phase 2)Ended earlyNCT02202746
What this trial is testing

Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer

Who this might be right for
Breast CancerMetastatic Breast CancerMBC+5 more
Clovis Oncology, Inc. 178
Not applicableStudy completedNCT04855383
What this trial is testing

Intramuscular Injection of Human Chorionic Gonadotropin in Frozen Embryo Transfer Cycles

Who this might be right for
Embryo Implantation
Royan Institute 200
Not applicableStudy completedNCT01613131
What this trial is testing

Mirena and Estrogen for Control of Perimenopause Symptoms and Ovulation Suppression

Who this might be right for
Menopausal and Other Perimenopausal Disorders
University of Colorado, Denver 39
Testing effectiveness (Phase 2)Study completedNCT00332553
What this trial is testing

Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen

Who this might be right for
Vasomotor SymptomsEndometrial Safety
Eli Lilly and Company 150
Post-approval studies (Phase 4)Looking for participantsNCT06610305
What this trial is testing

Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression

Who this might be right for
Major Depressive Disorder
University of North Carolina, Chapel Hill 75
Testing effectiveness (Phase 2)Ended earlyNCT01874756
What this trial is testing

The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia

Who this might be right for
Schizophrenia
Indiana University 95
Not applicableStudy completedNCT00115505
What this trial is testing

Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer

Who this might be right for
Breast Carcinoma
Alliance for Clinical Trials in Oncology 307
Early research (Phase 1)Study completedNCT01344031
What this trial is testing

MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor PositiveInvasive Breast CarcinomaRecurrent Breast Carcinoma+1 more
National Cancer Institute (NCI) 31
Not applicableStudy completedNCT00668252
What this trial is testing

Circulating Endothelium Progenitor Cells and Endogenous Oestrogen in Healthy Subjects

Who this might be right for
Healthy
Assistance Publique - Hôpitaux de Paris 48
Not applicableStudy completedNCT01723917
What this trial is testing

Phytoserms for Menopause Symptoms and Age-Associated Memory Decline

Who this might be right for
Hot FlashesMemory Loss
University of Southern California 71
Early research (Phase 1)Study completedNCT02123823
What this trial is testing

BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer

Who this might be right for
Neoplasms
Boehringer Ingelheim 164
Next Page